NEW YORK CITY – With flicks like "Sister Act," "Jumpin' Jack Flash," and "The Associate" (a personal favorite and a film I believe is greatly underrated), comedic actress Whoopi Goldberg has made a career out of making folks laugh.
But in one of those odd ironies of life, Goldberg was serious – even downright somber – during her appearance at a conference here on the last day of last month as she talked about the sorrow felt by the parents of epilepsy-afflicted children.
"I know dozens of families with children with epilepsy. You see your child disappear," she said, referring to what happens after kids are prescribed traditional seizure medications. "But then you find something better… and the seizures go away."
It was here when Goldberg experienced a mood shift – from somber to mad – as she addressed one of the most frustrating and sorrowful catch-22s in medicine today.
I'm talking about the catch-22 that occurs when the solutions to medical maladies are kicked to the curb when our "elected elite" decide to politicize them.
Now, we've addressed this frustrating conundrum here before in the area of chronic pain.
You see, even though chronic pain is a growing, ever more costly problem here in the United States, elected officials in Washington and at the state level have so politicized pain medications that patients with real afflictions are finding it difficult to find treatment programs.
It turns out childhood epilepsy sufferers are in a similar boat; Goldberg sketched out a similar scenario with childhood epilepsy.
She noted that cannabidiol (also known as CBD) – which comes from the marijuana plant but does not have psychoactive effects like tetrahydrocannabinol (THC), the chemical that gets users high – has been used with some success by parents to halt epileptic seizures in their children.
But that success comes with a backlash.
You have successes, Goldberg said, "and then, child services wants to take [the] child away. That is wrong."
The actress didn't let up at all…
About the Author
Before he moved into the investment-research business in 2005, William (Bill) Patalon III spent 22 years as an award-winning financial reporter, columnist, and editor. Today he is the Executive Editor and Senior Research Analyst for Money Morning. With his latest project, Private Briefing, Bill takes you "behind the scenes" of his established investment news website for a closer look at the action. Members get all the expert analysis and exclusive scoops he can't publish... and some of the most valuable picks that turn up in Bill's closed-door sessions with editors and experts.